TNF Receptor 2 & Fc fragment Region (human IgG1) Protein

Artikelnummer: ABB-YR0143
Artikelname: TNF Receptor 2 & Fc fragment Region (human IgG1) Protein
Artikelnummer: ABB-YR0143
Hersteller Artikelnummer: YR0143
Alternativnummer: ABB-YR0143-20MG,ABB-YR0143-1MG,ABB-YR0143-5MG
Hersteller: ABclonal
Kategorie: Antikörper
Applikation: ELISA, NeA
Alternative Synonym: TNFBR, TNFR2
Etanercept, a fusion protein of the soluble TNF receptor 2 and a Fc fragment (human IgG1 isotype). Etanercept can be used to treat autoimmune diseases by interfering with tumor necrosis factor (TNF), a soluble inflammatory cytokine, by acting as a TNF inhibitor. TNF alpha is the master regulator of the inflammatory (immune) response in many organ systems. Autoimmune diseases are caused by an overactive immune response. Etanercept has the potential to treat these diseases by inhibiting TNF alpha. Etanercept binds to TNF alpha and decreases its role in disorders involving excess inflammation in humans and other animals, including autoimmune diseases such as ankylosing spondylitis, juvenile rheumatoid arthritis, psoriasis, psoriatic arthritis, rheumatoid arthritis, and, potentially, in a variety of other disorders mediated by excess TNF alpha.
NCBI: 7133
UniProt: P20333
Reinheit: >95% Determined by SDS-PAGE
Target-Kategorie: TNFRSF1B
Application Verdünnung: In Vivo Grade Recombinant Human IgG1 Fc Protein
Anwendungsbeschreibung: Cross-Reactivity: <1EU/mg (<0.001EU/µg)Determined by LAL gel clotting assay. ResearchArea: Cancer immunology